Human epidermal growth factor receptor-2 (HER2) tends to be overexpressed in 20–25% of breast carcinoma [3], and amplification of the gene has been proven to play a crucial role in tumour growth and progression [4]. This evidence concerns the gene ERBB2 and breast carcinoma.